The findings, reported in the journal Nature Communications, provide a new understanding of how cells control gene activity and could have implications for the development of new drugs and therapies to treat genetic diseases, cancer and other conditions.
Gene promoters are regions of DNA located just upstream of genes, where the genetic information carried by DNA is transcribed into RNA molecules that are then used to produce proteins. Promoters control the rate at which genes are expressed, determining how much protein is produced.
Scientists have long known that promoters contain specific sequences of nucleotides, the building blocks of DNA, that are recognized by proteins called transcription factors. These transcription factors bind to the promoters and initiate transcription, the process of copying the genetic code into RNA.
However, the specific mechanisms by which promoters regulate gene expression have remained poorly understood.
In the new study, the researchers used a combination of experimental techniques and computational modeling to investigate how promoters control gene expression in the bacterium *Escherichia coli*. They found that the key lies in the spacing and arrangement of the nucleotide sequences recognized by transcription factors.
The researchers found that the optimal spacing between these sequences, known as the "spacing window," is crucial for gene expression. When the spacing is too short or too long, transcription is inhibited.
The researchers also found that the arrangement of these sequences, known as the "sequence composition," is important for gene expression. Promoters with a higher density of the recognized sequences tend to be more active, while promoters with a lower density are less active.
"Our study provides a new understanding of how promoters regulate gene expression," said NIST's Dr. Michael Lynch, one of the lead authors of the study. "This could open up new avenues for developing drugs and therapies to treat genetic diseases, cancer, and other conditions."
One potential application of this research is in the development of gene therapy, which aims to treat diseases by altering the expression of genes. By understanding how promoters control gene expression, scientists could design drugs or therapies that target specific promoters and modify the activity of the genes they control.
The researchers are continuing to investigate how promoters regulate gene expression in other organisms, including humans. They are also working to develop new methods for predicting the activity of promoters, which could be used to design more effective gene therapies.
